Your Source for News about Stem Cells and CRISPR
Latest news from all over the web about stem cell research by category and topics of interest.
Latest News about Stem Cells at Your Fingertips
We aggregate and curate news from all over the web and social media, organizing them by categories and topics of interest, so you could make your own decisions about events, technologies and people connected with stem cell therapies.
Weekly reads on organoids, COVID, CRISPR, cold chromatin, more
As a researcher, is there ever enough time to get to everything that you want to read especially in newer areas like stem cells, organoids, [...]
UTSW Scientist: 'We Need More Women Thinking Creatively in the Lab and Pushing Science …
[Image: Oleksandr Bushko/istockphoto] It’s rare to have a woman winning a Nobel Prize, much less two women on the same day and three in the [...]
Taking Gene Editing to the Brain, the Immune System, and More
One of the most remarkable recent advances in biomedical research has been the development of highly targeted gene-editing methods such as CRISPR that can add, [...]
Explained: CRISPR Gene Editing, Winner of 2020 Chemistry Nobel Prize
Scientists discovered some bacteria can cut the DNA of invading viruses as a defence mechanism. They realised they could use this to cut human DNA. [...]
The Global Stem Cell Therapy Market Growth To 2023 Will Be Driven By Increasing Prevalence Of …
"Global Stem Cell Therapy Market, Forecast Market Size, 2019 – 2023, $ Billion"The Business Research Company’s Global Stem Cell Therapy Market Report 2020-30: Covid 19 [...]
Nobel win highlights Li Ka-shing role in medical research
HONG KONG -- Li Ka-shing may have dropped out of school at age 12, but that lack of educational achievement did not stop Hong Kong's [...]
Options for treating sickle cell disease expanded last fall
Two new therapy options won Food and Drug Administration approval within 10 days of each other in November 2019, blooms of hope in what has [...]
A small switch with a big impact
Minor changes in immune cells can significantly affect the immune response, scientists of the University of Würzburg have now discovered. Their findings could be relevant [...]
Gladstone researchers awarded $3.2 million to study cellular energy
A team of Gladstone researchers has received a grant of more than $3.2 million from the National Institutes of Health (NIH) to study how cells [...]
Timothy Ray Brown, First Person to Be Cured of HIV, Dies
Timothy Ray Brown, who became the first HIV patient to be cured of the infection, died September 29 of leukemia—the very disease that led to [...]
Parkinson's research at UC Berkeley funded by $14 million grant
Two grants totaling nearly $14 million to be distributed over three years have been awarded to fund research at UC Berkeley on the causes of [...]
Qihan Biotech Expands Scientific Advisory Board and Establishes Scientific Advisory Committees
Sept. 29, 2020 15:50 UTC HANGZHOU, China--(BUSINESS WIRE)-- Qihan Biotech, a leader in applying genome editing technology to cell therapies and organ transplantation, today announced [...]
Orphan Drug Exclusivity for CRISPR/Cas-Based Therapeutics
Monday, September 28, 2020 The prospect of genetic engineering using CRISPR (clustered regularly interspaced short palindromic repeats) and CRISPR-associated nucleases (Cas) has long been hailed [...]
Rebuilding retina to restore sight
Fresh from their role in developing the world’s most detailed retinal gene atlas, our cellular reprogramming unit is using this knowledge to develop pioneering new [...]
Type 1 diabetes from a beta cell's perspective.
Type 1 diabetes is an autoimmune disease that occurs when T-cells in the immune system attack the body’s own insulin-producing cells, called beta cells, in [...]
Next generation strategies for cancer immunotherapy
12 November 2020 12 November 2020 ABOUT THIS WEBINAROver the past decade immunotherapy has emerged as a promising therapeutic strategy. However, treatment efficacy and resistance [...]
Gene-editing Therapy CTX001 Granted Priority Medicines Designation for Severe SCD in EU
CTX001, an investigational gene-editing cell therapy, has been granted priority medicines (PRIME) designation by the European Medicines Agency (EMA) for the treatment of severe sickle cell [...]
Vertex, CRISPR Therapeutics' sickle cell gene therapy wins PRIME designation
Vertex Pharmaceuticals and CRISPR Therapeutics have been awarded a Priority Medicines (PRIME) designation from the European Medicines Agency for their CRISPR/Cas9 gene therapy, designed to [...]
PLOS Papers on Dilated Cardiomyopathy, Lung Cancer Epigenetics, Pediatric Staphylococcus …
In PLOS Genetics, researchers from Israel and the US describe ties between an early-onset dilated cardiomyopathy (DCM) heart condition and a recessive mutation in the [...]
Scientists create gene-edited livestock as 'surrogate dads' to boost food production
In what is being hailed as a breakthrough, scientists have for the first time created gene-edited livestock — pigs, goats and cattle — that can [...]
In a first, gene-edited livestock that can act as 'surrogate dads' created
NEW DELHI: In what is being hailed as a breakthrough, scientists have for the first time created gene-edited livestock — pigs, goats and cattle — [...]
$14 million boost for Parkinson's disease research
(iStock image) Two new grants totaling nearly $14 million over three years will jump-start research at UC Berkeley into the molecular and genetic causes of [...]
Engineered stem cells could evade immune system rejection, study shows
By editing out a set of proteins on the surface of human pluripotent stem cells, researchers have ensured they will be not be rejected by [...]
Curi Bio Announces Mantarray™ Platform for Analysis of 3D Engineered Muscle Tissues for …
#inform-video-player-1 .inform-embed { margin-top: 10px; margin-bottom: 20px; } #inform-video-player-2 .inform-embed { margin-top: 10px; margin-bottom: 20px; } SEATTLE--(BUSINESS WIRE)--Sep 15, 2020--Curi Bio, a leading developer of [...]
ERS Genomics, Applied StemCell Ink Commercialization Agreement for CRISPR Services, Reagents
NEW YORK – ERS Genomics, a vessel for intellectual property held by CRISPR pioneer Emmanuelle Charpentier, announced Tuesday a licensing deal with Applied StemCell.Under the [...]